Exact Sciences
EXAS
#1782
Rank
NZ$15.66 B
Marketcap
$84.61
Share price
-2.28%
Change (1 day)
-15.85%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$5.96 Billion

According to Exact Sciences's latest financial reports the company's total liabilities are NZ$5.96 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$5.25 B4.88%
2022-12-31NZ$5.01 B3.88%
2021-12-31NZ$4.82 B29.51%
2020-12-31NZ$3.72 B106.16%
2019-12-31NZ$1.80 B43.86%
2018-12-31NZ$1.25 B1042.33%
2017-12-31NZ$0.11 B82.57%
2016-12-31NZ$60.26 M10.96%
2015-12-31NZ$54.31 M78.51%
2014-12-31NZ$30.42 M121.06%
2013-12-31NZ$13.76 M-16.27%
2012-12-31NZ$16.43 M-4.66%
2011-12-31NZ$17.24 M-20.63%
2010-12-31NZ$21.72 M-19.8%
2009-12-31NZ$27.08 M88.7%
2008-12-31NZ$14.35 M32.38%
2007-12-31NZ$10.84 M-14.25%
2006-12-31NZ$12.64 M-34.63%
2005-12-31NZ$19.34 M-23.84%
2004-12-31NZ$25.4 M-26.45%
2003-12-31NZ$34.54 M54.01%
2002-12-31NZ$22.42 M125.32%
2001-12-31NZ$9.95 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$0.58 B-90.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.16 B-97.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$36.79 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$102.63 B 1,619.69%๐Ÿ‡ซ๐Ÿ‡ท France